What’s Next After The 15% Rally For Sangamo Therapeutics Stock Last Week?

Earlier this month, we discussed that the stock price of Sangamo Therapeutics, a biotechnology company that focuses on multiple areas in the genomic medicine space, may trend higher in the near term, based on the company’s robust pipeline, and our machine learning analysis. SGMO stock has seen...